PGEN

Precigen
PGEN

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.23B
EV
$1.21B
Shares Outstanding
297.97M
Beta
1.16
Industry
Biotechnology

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
Number of Analysts
2
P/E 2025E
-
P/Revenue 2025E
91.26x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Precigen, Inc.

gainify
PGEN

Precigen, Inc.

PGEN

Precigen, Inc. operates as a discovery and clinical-stage biopharmaceutical company that develops gene and cell therapies using precision technology to target diseases in therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. It operates ...

Sector

Healthcare

Industry

Biotechnology

CEO

Sabzevari, Helen

Employees

143

IPO Date

2013-08-08

Headquarters

20358 Seneca Meadows Parkway, Germantown, Maryland, 20876, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.